z-logo
open-access-imgOpen Access
Aktuelles rund um Imatinib
Author(s) -
Johannes Wolff,
Jennifer Finlay,
K Altundag,
Alexander Schmittel,
Konrad Schulze,
Gero Hütter,
Petra Krebs,
E. Thiel,
Ulrich Keilholz,
Selim Yalçın,
Ozan Özkaya,
Necdet Güler,
Andreas S. Lübbe,
Wolfgang Grisold,
M. J. van den Bent,
Roger Stupp,
Alina Brandes,
D Lacombe,
D. Reinhardt,
Sylke Diekamp,
Gudrun Fleischhack,
C. Corbacioglu,
Hella Jürgens,
M. Dworzak,
G.J.L. Kaspers,
Ursula Creutzig,
C. Michel Zwaan,
Jean-Claude Ruf,
Holger Amthauer,
Helmut Oettle,
Th. Steinmüller,
Michail Plotkin,
Uwe Pelzer,
Hans-Joachim Scholman,
R Felix,
Patricia Wüst,
Jonathon Sturm,
Michael Keese,
W. Golder,
Ralph Dollner,
C. Granzow,
Juliana Werner,
Andrew C. Dietz,
William J. Dona Wick,
Wilhelm Küker,
Andrea Křivanová,
Richard A. Hajek,
Miroslav Krejčí,
Vlastimil Ščudla,
Karel Indrák,
J Bačovský,
Tomáš Büchler,
Adam Svobodník,
Zdeněk Adam,
Jan Mayer,
Jiří Vorlíček,
Raymond Voltz,
Francesc Graus
Publication year - 2004
Publication title -
oncology research and treatment
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.553
H-Index - 48
eISSN - 2296-5262
pISSN - 2296-5270
DOI - 10.1159/000079461
Subject(s) - imatinib , medicine , myeloid leukemia

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here